alkermes plc (ALKS:NASDAQ GS)
Earnings & Estimates Summary - ALKERMES PLC (ALKS)
2013 revenues at Alkermes plc totaled $596.3M USD, while annual earnings equaled $1.19 per share.
Quarterly Earnings & Estimates - ALKERMES PLC (ALKS)
Alkermes plc's Quarterly Earnings
Alkermes plc reported 2nd quarter 2014 on 08/2/2014.
Annual Earnings & Estimates - ALKERMES PLC (ALKS)
Alkermes plc's Annual Earnings
Alkermes plc reported annual 2013 earnings of $1.19 per share on 03/1/2014.
Quarterly Revenues - ALKERMES PLC (ALKS)
Annual Revenues - ALKERMES PLC (ALKS)
Alkermes plc's Annual Revenues
Alkermes plc had revenues for the full year 2013 of $596.3M USD. This was 52.9% above the prior year's results.
|BioMarin Pharmaceutical Inc||$108.42 USD||+1.35|
|Impax Laboratories Inc||$40.45 USD||+0.16|
|Lupin Ltd||1,797 INR||+50.00|
|Pacira Pharmaceuticals Inc/DE||$92.30 USD||-22.47|
|Salix Pharmaceuticals Ltd||$156.88 USD||-0.32|
|View Industry Companies|